References
- Kenyon K R, Navon S E. Corneal manifestations of metabolic diseases. Cornea, J H Krachmer, M J Mannis, E J Holland. Mosby, St. Louis 1997; Vol. II: 897–924
- Shah G K, Cantrill H L, Holland E J. Vortex keratopathy associated with atovaquone. Am J Ophthalmol 1995; 120(5)669–671
- Kaplan L J, Cappaert W E. Amiodarone keratopathy: correlation to dosage and duration. Arch Ophthalmol 1982; 100: 601–602
- Nielsen C E, Andreasen F, Bjerregaard P. Amiodarone induced cornea verticillata. Acta Ophthalmol 1983; 61: 474–480
- D'Amico D J, Kenyon K R, Ruskin J N. Amidarone keratopathy: drug induced lipid storage disease. Arch Ophthalmol 1981; 99: 257–261
- Pollack P T. Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations. Am J Cardiol 1999; 84: 37R–45R
- Raeder E A, Podrid P J, Lown B. Side effects and complications of amiodarone therapy. Am Heart J 1985; 109: 975–983
- Buscemi P M. Clinical experience with the confoscan 2 corneal confocal microscope. J Refract Surg 2000; 16: S276–S280
- Ciancaglini M, Carpineto P, Zuppardi E, Nubile M, Doronzo E, Mastropasqua L. In vivo confocal microscopy of patients with amiodarone induced keratopathy. Cornea 2001; 20(4)368–373
- Orlando R G, Dangel M E, Schaal S F. Clinical experience and grading of amiodarone keratopathy. Ophthalmology 1984; 91: 1184–1187
- Cavanagh H D, Petroll W M, Alizadeh H, He Y G, McCulley J P, Jester J V. Clinical and diagnostic use of in vivo confocal microscopy in patients with corneal disease. Ophthalmology 1993; 100: 1444–1454
- Soto L O, Efron N. Morphology of corneal nerves using confocal microscopy. Cornea 2001; 20(4)374–384
- Grupcheva C N, McGhee C NJ. In vivo confocal microscopy of patients with amiodarone‐induced keratopathy. Cornea 2002; 21(4)430–431
- Ghosh M, McCulloch C. Amiodarone‐induced ultrastructural changes in human eyes. Can J Ophthalmol 1984; 19(4)178–186
- Yılmaz N, Örnek K, Kanpolat A. Kornea hastalıklarında konfokal mikroskobun klinik kullanımı (ön çalıcşma). MN Oftalmol 2001; 8(2)132–136